Drug Trial Radar · NCT07121595
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Last checked: Nov 20, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Jul 17, 2025
Primary completion
Jul 1, 2030
Study completion Jul 1, 2030
Sponsor
- Lead sponsor
- University of Michigan Rogel Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 13, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well personalized neck radiation therapy directed by sentinel lymph node biopsy (SLNB) works in treating patients with oral cavity squamous cell carcinoma (OCSCC). SLNB can be performed as part of standard care for OCSCC. During SLNB, a radiotracer is injected around the tumor. The lymph nodes are then biopsied and tested to see if the tracer injected into the tumor traveled to and is present in the sentinel lymph nodes (SLNs). Results of the SLNB are used to determine whether lymph nodes should be removed in both sides of the neck or just on the same side as the primary tumor. Standard treatment then involves radiation therapy to both sides of the neck, regardless of SLNB results. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill tumor cells and shrink tumors. Studies have shown only a small number of patients develop a return of the cancer (recurrence) in the opposite side of the neck after radiation therapy. In addition, radiation therapy can negatively impact patient outcomes like saliva production, speech and swallow function, increased risk of radiation induced cancers, and chronic pain. Standard of care SLNBs may be effective in determining whether radiation therapy only needs to be administered to one side of the neck or both sides. This may help spare tissue on the opposite side of the neck from receiving radiation if there is no indication of lymph node involvement there.
Conditions
- Oral Cavity Squamous Cell Carcinoma
- Stage I Lip and Oral Cavity Cancer AJCC v8
- Stage II Lip and Oral Cavity Cancer AJCC v8
- Stage III Lip and Oral Cavity Cancer AJCC v8
- Stage IVA Lip and Oral Cavity Cancer AJCC v8
Interventions
Biospecimen CollectionProcedure
Undergo blood sample collection
CarboplatinDrug
Given IV
CisplatinDrug
Given IV
Computed TomographyProcedure
Undergo CT and/or SPECT-CT
Modified Barium SwallowProcedure
Undergo video fluoroscopic swallow study
PaclitaxelDrug
Given IV
Positron Emission TomographyProcedure
Undergo PET-CT
Questionnaire AdministrationOther
Ancillary studies
Radiation TherapyRadiation
Undergo RT
Sentinel Lymph Node BiopsyProcedure
Undergo SLNB
Single Photon Emission Computed TomographyProcedure
Undergo SPECT-CT
Technetium Tc 99m-labeled TilmanoceptRadiation
Given via injection
Technetium Tc-99m Sulfur ColloidOther
Given via injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contralateral regional control rateTime frame: From completion of definitive treatment to neck recurrence date, death date or date of last contact, assessed at 1 year from completion of definitive treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.